All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 3, 2022
Home » Topics » Financings, BioWorld Asia

Financings, BioWorld Asia
Financings, BioWorld Asia RSS Feed RSS

Dollar arrows pointing upward

Teclison raises $5.9M to advance solid tumor program

March 1, 2022
By Doris Yu
No Comments

Teclison Ltd. has raised $5.9 million to support further development of its lead candidate, TEC-001, an agent designed to induce tumor necrosis and enhance immune checkpoint inhibitors in solid cancers with liver metastasis. Wtt Investment Ltd., the Taiwan-based family office of the late Taiwanese banker Tsai Wan-tsai, led the financing.


Read More

Financings for March 1, 2022

March 1, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Biorchestra, Priothera.
Read More
HKEX exterior

Lepu Biopharma raises $115.9M to invest in ADC and PD-1/L1 drugs

March 1, 2022
By Doris Yu
No Comments
Lepu Biopharma Co. Ltd. started trading on the Hong Kong stock exchange on Wednesday, raising HK$904 million ($115.9 million) in an initial public offering. Trading opened at HK$7.13 per share and slid to HK$6.70 by midday before closing at HK$7.13.
Read More
South Korean won

Biorchestra to develop RNA-based treatment for neurodegenerative diseases with $45M series C funding

March 1, 2022
By Gina Lee
No Comments
Biorchestra Co. Ltd. has raised ₩54 billion ($45.1 million) in its latest series C fundraising, which will boost the development of the company’s lead RNA-based candidate for treating neurodegenerative diseases.
Read More

Financings for Feb. 22, 2022

Feb. 22, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Delos Capital, Grand Pharma, ITM Isotope Technologies Munich.
Read More

Financings for Feb. 15, 2022

Feb. 15, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Bugworks Research, Ethris, Linkinvax, Merck, Statera, TC, Teclison, Ucello.
Read More

Financings for Feb. 1, 2022

Feb. 1, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Ractigen, Hanbio, Veneno.
Read More
IPO, coins, financial chart

Mabwell raises ¥3.48B in Shanghai IPO, though shares meet cool reception

Jan. 25, 2022
By Doris Yu
No Comments
Mabwell Bioscience Co. Ltd. raised ¥3.48 billion ($547.9 million) in a Shanghai STAR Market IPO on Jan. 18 to support company R&D efforts and plans to build an antibody production plant. Though oversubscribed, the offering got a cool market reception, with shares plunging nearly 30% from a ¥32 open (US$27.96), then closing at ¥24.50 on the first day of trading before recovering slightly to ¥27.40 on Jan. 20.
Read More
Eye and DNA

Cellusion raises $9.5M to support ocular cell therapy

Jan. 18, 2022
By Gina Lee
No Comments
Cellusion Inc. recently closed a ¥1.1 billion ($9.5 million) financing, bringing its total 2021 fundraising to ¥1.7 billion. The company is preparing to enter the clinic with CL-S001, its corneal endothelial substitute cell candidate for treating corneal edema due to endothelial dysfunction, or bullous keratopathy.
Read More

Financings for Jan. 18, 2022

Jan. 18, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Celsion, Claritas, Geovax Labs, Pfizer, Postera.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 33 34 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for July 1.
  • Novavax-COVID-19-vaccine-vial

    Novavax vaccine shows its chops

    BioWorld
    Given that Novavax Inc.’s COVID-19 vaccine will be a latecomer to the U.S. scene if it gets FDA authorization, it’s been cast in a supporting role to the lead...
  • Blood sample, DNA

    Biomarin outlines pricing strategy for costly hemophilia A gene therapy after backing from European regulators

    BioWorld
    The first gene therapy to treat severe hemophilia A was among the drugs recommended for European approval by regulators from the EMA’s CHMP at its monthly...
  • Cells and DNA helix

    Bluebird’s eli-cel gene therapy for CALD snatches adcom victory from jaws of defeat

    BioWorld
    The Cellular, Tissue and Gene Therapies Advisory Committee scrutinized Bluebird Bio Inc.’s gene therapy elivaldogene autotemcel (eli-cel) for early active...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing